BRIEF RESEARCH REPORT
Accepted on 23 Jul 2025
Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipients
doi 10.3389/fimmu.2025.1601385
- 137 views
- Frontiers in Immunology
- Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- Research Topics
- Repurposing Cancer Immunotherapies for Use in Autoimmunity and Transplantation
Repurposing Cancer Immunotherapies for Use in Autoimmunity and Transplantation
15k
Total downloads
54k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 01 Jul 2025
CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organs
doi 10.3389/fimmu.2025.1513009
- 2,173 views
BRIEF RESEARCH REPORT
Published on 18 Dec 2023
An orally available cancer drug AZD6738 prevents type 1 diabetes
doi 10.3389/fimmu.2023.1290058
- 1,599 views
- 1 citation
ORIGINAL RESEARCH
Published on 30 May 2023
Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8+ T cells
doi 10.3389/fimmu.2023.1142648
- 4,813 views
- 7 citations
ORIGINAL RESEARCH
Published on 10 May 2023
Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus
doi 10.3389/fimmu.2023.1115244
- 2,043 views
- 2 citations
REVIEW
Published on 19 Apr 2023
Opportunities for Treg cell therapy for the treatment of human disease
doi 10.3389/fimmu.2023.1166135
- 18,448 views
- 63 citations
REVIEW
Published on 14 Dec 2022
The emerging role of regulatory cell-based therapy in autoimmune disease
doi 10.3389/fimmu.2022.1075813
- 12,572 views
- 62 citations
MINI REVIEW
Published on 16 Nov 2022
The dichotomous outcomes of TNFα signaling in CD4+ T cells
doi 10.3389/fimmu.2022.1042622
- 7,915 views
- 3 citations
